While there’s no cure for migraine, there are various treatments to address its symptoms and side effects, including medication or lifestyle changes. Chiropractic treatments are one type of ...

Calcitonin gene-related peptide (CGRP) inhibitors are now considered a first-line treatment used to treat and prevent migraines. There are two types of CGRP medications: monoclonal antibodies and ...

A 2021 systematic review and meta-analysis compared triptans, ditans, and gepants for migraine treatment. Researchers found that triptans were more effective at reducing pain within 2 hours ...

In addition to spinal adjustments, chiropractors may recommend lifestyle changes or other therapies to help people find relief from headaches and migraines. Despite the potential benefits, there are ...

How should she be evaluated and treated? What is the probable migraine type and the drug of choice for its treatment and long-term management?

Sumatriptan, naratriptan and others, referred to as 'triptans', are the mainstay for acute treatment of migraine. Ergot alkaloids (ergotamine, dihydroergotamine) are used in patients with frequent ...

Background: OnabotulinumtoxinA (BoNT-A) is approved as a prophylactic treatment of chronic migraine (CM) only. We aimed to assess the efficacy and safety of BoNT-A in the treatment of episodic ...

TMJ could be one source of tension that can lead to increased migraines, and treating it can be helpful. Ice or a cold compress can be a lifesaver when it comes to acute treatment for a blistering ...

Atogepant, a recently approved drug for migraine, may start working as soon as day 1 of treatment, according to a recent study published in Neurology. "With many current drugs to prevent migraine, it ...

People suffering from severe migraines in Scotland will be able to get treatment with Amgen and Novartis’ Aimovig if they fail other therapies, according to the country’s cost-effectiveness ...

Experts from as far afield as the US and Brazil will discuss the latest headache and migraine treatments and research at the tenth biennial National Meeting on Headache, hosted in Hull.